New South Wales, Australia

Robin Gasiorowski

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will provide you with the requested article on inventor Robin Gasiorowski.

Title: Spotlight on Inventor Robin Gasiorowski

Introduction:

Robin Gasiorowski, a talented inventor hailing from New South Wales, AU, has made significant contributions to the field of biotechnology. With a keen focus on therapeutic antibodies, he has a patent that stands out for its innovative approach.

Latest Patents:

Gasiorowski's notable patent is for the "Anti-CD300F antibody and uses thereof." This patent revolves around an isolated antibody that specifically targets the extracellular domain of CD300F. The antibody's unique characteristics and potential therapeutic applications make it an exciting development in the biotech industry.

Career Highlights:

Currently associated with Dendrocyte Biotech Pty Ltd, Robin Gasiorowski brings his expertise to the forefront of cutting-edge research and development in the biotech sector. His dedication to innovation and scientific excellence is evident in his work and patent portfolio.

Collaborations:

In his professional journey, Gasiorowski has collaborated with accomplished individuals in the field, including Derek Nigel John Hart and Georgina Jane Clark. These collaborations have enriched his projects and led to the successful development of groundbreaking solutions.

Conclusion:

In conclusion, Robin Gasiorowski's inventive spirit and commitment to advancing biotechnology underscore his impact in the industry. His patent for the Anti-CD300F antibody exemplifies his ingenuity and dedication to creating novel therapeutic solutions. As he continues to push the boundaries of innovation, Gasiorowski remains a driving force in the realm of biotech inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…